Cardiac device makers Edwards, JenaValve elicit US FTC merger challenge
Cardiology technology developer Edwards Lifesciences Corporation’s proposed $945 million acquisition of rival JenaValve Technology was challenged in a lawsuit filed today by the US Federal Trade Commission, whose three Republican commissioners...To view the full article, register now.
Already a subscriber? Click here to view full article